Immunogenicity of Guselkumab (GUS) Among Psoriasis Patients in VOYAGE (VOY) 1&2 Studies. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 6, n. 2, p. s11, 2022. DOI: 10.25251/skin.6.supp.11. Disponível em: https://skin.dermsquared.com/skin/article/view/1528. Acesso em: 22 may. 2026.